Technology Transfer - International Environmental Technology Centre
The Technology Of Microbiological Environmental · PDF fileThe Technology Of Microbiological...
Transcript of The Technology Of Microbiological Environmental · PDF fileThe Technology Of Microbiological...
© Silliker Australia 2010
The Technology OfMicrobiologicalEnvironmental
Monitoring
Stephen JaySenior Consultant Microbiologist
ChairmanSilliker Australia
CAPSIG Wednesday 7th July 2010
2© Silliker Australia 2010
Presentation PlanMicrobiological Environmental Monitoring
Standards and guidanceWhen to sampleSampling plansSample site selectionSampling frequencyHow to sample:•Sampling surfaces•Sampling air
ValidationQuality of growth mediaCharacterisation of microfloraAnalysis of dataEmphasis on cleanrooms and aseptic areas
3© Silliker Australia 2010
Standards And Guidance
General :• ISO 14644 series - Cleanrooms and associated controlled environments• ISO 14698 series - Cleanrooms and associated controlled environments -
Biocontamination controlTherapeutic :• TGA - PIC/S Guide to Good Manufacturing Practice for Medicinal Products
•Annex 1 for manufacture of sterile medicinal products + technical interpretationof Annex 1
•USP chapter 1116• EU GMP Guidelines :
•Annex 1 for sterile products•PDA documents :
•Environmental Monitoring: A Comprehensive Handbook, Volume I, II, III, IV•Technical Report 13 - Fundamentals of an Environmental Monitoring Program
(1990)•Technical Report 49–Points to Consider for Biotechnology Cleaning Validation
(2010)• Journal articles, especially J Pharm Sci Technol•Pharmaceutical Microbiology Forum (PMF)–www.microbiologyforum.org
4© Silliker Australia 2010
When To Sample
When microbiological contamination is important to theprocesses and products
When the facility is used for manufacture of therapeuticproducts including medical devices that are to be suppliedmicrobiologically clean
When the facility is used for manufacture of therapeuticproducts including medical devices that are to be suppliedsterile
Cleanrooms used for electronic assembly and the like usuallydo not need microbiological monitoring as viable particles arejust particles. An exception might be the water supply
5© Silliker Australia 2010
When To Sample
When built–initial investigations for commissioning
Periodic certification
After breaches of alert/action levels
After breaches of hygiene security
In operation - routine monitoring for performancemaintenance
6© Silliker Australia 2010
Sampling Plan
Logical to perform a large and intense sampling of areas (qualification orbaseline study) prior to deciding on the routine and usually reducedsampling plan. Qualification air sampling: Number of sites =√area in m2
Logical to sample more frequently as the criticality of the area increasesLogical to allow for investigative sampling within a formal plan whereparticular designated sites are always sampledShould address risk of sampling introduced contaminationSampling plans should be dynamic with monitoring frequencies andsample locations adjusted based on trending performance. It isappropriate to increase or decrease sampling based on this performance–R. Tirumalai USP, 2009, www.usp.orgSampling should occur at the same sites and at the same time of day.This will make analysis and trending of data more meaningful by reducingthe variables. It is recommended to sample during peak activity torepresent worse case - Anne Booth, www.gsfcc.orgUse worst-case situation?•Statistical analysis of environmental monitoring data: does a worst case time
for monitoring clean rooms exist? Cundell et al, J Pharm Sci Technol, Vol. 52, No.6, 1998
7© Silliker Australia 2010
Sampling Plan
Frequency of sampling increases as the importance(criticality) of the zone increases
Zone 4Remote areas: hallways, doors, coolers, cafeteria, etc.
Zone 3Non-product contact surfaces:
Floors, walls, drains, leg supports, wheeled items, forklifts, etc.
Zone 2Non-product contact surfaces:
Exterior of equipment, control panel / buttons, tables, etc.
Zone 1Product contact surfaces:
Conveyors, fillers, pipes, storage vessels, utensils,scrapers
8© Silliker Australia 2010
Sample Site Selection
Conduct a risk analysis and develop a rationale for thesampling locations and frequency:•Where microbial contamination is likely to occur•Where microbial proliferation is likely to occur•Where microbial accumulation is likely to occur•Where most activity occurs•Where it is difficult to clean•Where personnel are working
EM Qualification sample site selection, PharmaceuticalMicrobiology Forum Newsletter–Vol. 14 (8),www.microbiologyforum.orgEstablishment of critical contamination risk locations (“Hot Spots”) in environmental monitoring by means of three-dimensional airflow analysis and particulate evaluation,Katayama et al, J Pharm Sci Technol, Vol. 63, No. 3, 2009
9© Silliker Australia 2010
Sample Site Selection
Far surfaces•Walls•Floor•Ceiling•Doors, especially areas that are
contacted by peopleNear surfaces–nearproduct contactsurfaces•Exterior of equipment•Control panels•Control buttons•Tables
Product contact surfaces•Bench and table tops•Crates or boxes that hold product
or parts•Equipment product contact
surfacesPersonnel•Gloves•Garments
AirCompressed gases if they exitinto a cleanroom or contactproductWaterAqueous solutions oremulsions
10© Silliker Australia 2010
Frequency Of Sampling
Medical device manufacture, terminally sterilised devices andclean pharmaceutical manufacture - weekly, fortnightly,monthly, quarterly - depending on the process. Less thanquarterly is probably not sufficient
Aseptic fill/assembly - hourly, per operator session, per shift,daily - depending on the process. Less than per shift isprobably not sufficient
Sterility testing - per operator session, per test - depending onthe testing logistics. Less than per operator session is notadequate
11© Silliker Australia 2010
How To Sample
Surfaces :•Swabs•Contact agar plates, films or
slides•PetrifilmTM
•Liquid rinse
Air :•Settle agar plates, films or slides•Active air sampling :
• Impact to agar sampling• Filtration• Liquid entrapment• Optical spectroscopy
Compressed gases :•Filtration•Liquid entrapment
Water and other liquids :•Filtration•Surface agar plating•Agar pour plates•MPN methods•ATP
Personnel :•Swabs•Agar contact
12© Silliker Australia 2010
Sampling Surfaces
The methods are inaccurate and may provide highly variabledataSwab or agar contact may recover ~20-80% of the flora present–very dependent on operator training and experience. It iseasy to get false low results–e.g. dry swab on dry surfaceSwab developments:•Flocked swabs - Giblerto Dalmaso et al, J Pharm Sci Technol Vol. 62,
No. 3, 2008•MSSS™ swab system - Sandy Rubio, et al, J Pharm Sci Technol Vol. 64,
No. 2, 2010The liquid rinse technique is difficult, time consuming andshould be confined to special situations that might demand ithowever it is likely that it is the best technique•Microbiological sampling of surfaces, Faverom et al, J App Bact, Vol.
31 p 336-343, 1968
13© Silliker Australia 2010
Sampling Surfaces
Press withconsistentpressure for 10s•bioMérieux has a
device.
Swabs must berolled over thesurfacerepeatedly to beeffective.•It is easy to get false
low counts fromswabbing.
14© Silliker Australia 2010
Other Considerations
Microbiological methods do not recover all organisms thatmay be presentMedia residues are left on surfaces after samplingMicrobial counts under 25 CFU per test aliquot are statisticallyinaccurateA microbiological rule of thumb is that differences in microbialcounts of <1 log to 0.5 log do not indicate significantdifferences in population. In cleanroom monitoring, adifference of 1 CFU, depending on the type of productionoccurring, might be importantMicrobial counts from surfaces are at best semi-quantitative.They give an impression of the microbiological condition ofthe facility
15© Silliker Australia 2010
Sampling Air
Settle agar plates :•Estimate the number of viable particles
that settle on to a surface in a particulartime - the rate of contamination
•They can therefore be useful indetermining the possible contaminationof products. Refer to the work of Whyte, JPharm Sci Tech, 1981, 1983, 1984, 1996and Slater and Johnston, J Pharm SciTechnol, 1988
•Active vs passive air (settle plate)monitoring in routine environmentalmonitoring programs, Andon, J Pharm SciTechnol, Vol. 60, No. 6, 2006 Settle plate stand for
monitoring cleanrooms
16© Silliker Australia 2010
Sampling Air
Active air sampling - air samplers :
•Estimate the number of viable particles in air•Sampling technology has not been optimised :
•Data is device dependent:• Comparative study of airborne viable particles assessment methods in microbiological
environmental monitoring, Temprano, J Pharm Sci, Technol Vol. 58, No. 4, 2004• Impact to agar velocity is a balance between capturing small particles and not
causing excessive damage to the organisms• In liquid entrapment the velocity of air intake is important as is the bubble size•Filtration may dehydrate organisms and cause under estimation
No absolute scientific agreement on a relationship between theconcentration of nonviable particulates and viable microorganisms:•Airborne viable particles and total number of airborne particles:
comparative studies of active air sampling, Bengt Ljungqvist and BeritReinmu¨ Ller, J Pharm Sci Technol, Vol. 54, No. 2, 2000
•Environmental monitoring: A correlation study between viable andnonviable particles in clean rooms, Catherine Simõ Es De Abreu, J Pharm SciTechnol, Vol. 58 No. 1, 2004
18© Silliker Australia 2010
Other Considerations
Specific fungal and/or anaerobic monitoring?•Preliminary work can be done to show that strict
anaerobes and fungi are not a significant part of theproduction facility microflora and this can be used tojustify use of TSA for routine monitoring
•Most companies use TSA for routine monitoring, someuse SDA also
•Many companies internationally use dual incubation ofTSA at 30−35°C and 20−25°C to capture organisms that require lower temperatures like fungi•Comparative mold and yeast recovery analysis (the effect of differing
incubation temperature ranges and growth media), Marshall et al, JPharm Sci Technol, Vol. 52, No. 4 1998
19© Silliker Australia 2010
Validation
Validation of neutralisation of antimicrobial substances is important–bacteriostasis/fungistasisValidation of methods for recovery of microflora from surfaces, airand gases would be quite difficult for most laboratories and is usuallynot undertakenValidation of recovery from environmental sampling is not particularlyuseful because :•There is little scope for routine laboratories to improve methods and there
are many potential variables to investigate•Validation would result in a recovery correction factor, that is, a constant
used to adjust the data. Environmental microbial data is used to attempt todiscern trends. Trends can be determined without using a recovery constant–assuming methods remain constant
•Alert and action levels can be successfully applied to uncorrected data–assuming methods remain constant
•Many results from microbiologically critical areas are at the limit ofdetection for routine methods (0 CFU) and therefore applying a correctionfactor will give ‘less than’ data
20© Silliker Australia 2010
Quality Of Growth Media
Must be growth promotion tested
All agar plates, slides and films must be either pre-incubated to check for sterility or gamma irradiated
Diluents or broths used for MPN tests must belikewise treated
There must be no risk of false positive results fromcontamination of the media - unnecessary heartacheoccurs!
21© Silliker Australia 2010
Characterisation Of Flora
The effort expended on characterisation should be related to thepossible significance of the data
Mostly the flora of dry areas, e.g. cleanrooms, does not vary greatlywith respect to the main flora groupings. Microflora from cleanroomenvironments involved in aseptic production should be characterisedroutinely
Tracking variation in strain or genetic make up is a challenge foraseptic operations
Microbial identification strategies in the pharmaceutical industry,Cundell, J Pharm Sci Technol, Vol. 60, No. 2, 2006
22© Silliker Australia 2010
Cleanroom Flora
Common microorganisms :•Gram positive cocci•Gram positive sporing rods - Bacillus spp. - probably present as
sporesLess common microorganisms :•Moulds - probably present as spores and hyphael fragments•Yeast•Gram negative bacteria - usually associated with water,
wetted surfaces, solutions and emulsions. Common in watersystems
•CoryneformsThe bacterial diversity of pharmaceutical clean rooms analyzedby the fatty acid methyl ester technique, Pacheco and Pinto, JPharm Sci Technol, Vol. 64, No. 2, 2010
23© Silliker Australia 2010
Alert And Action Levels
The Alert Level is a level above which a drift from normalconditions is shown - prompt investigation and follow uprequired with possible remedial actionThe Action Level is a level above which results are notacceptable - immediate investigation and remedial actionrequiredAlert Levels often set at the 95 percentile of historical data, orat 2 x SD from the mean valueAction Levels often set at the 99 percentile of historical data, orat 3 x SD from the mean valueAction Levels also might be based on industry/compendialrecommendationsJudgement is needed to determine if the baseline obtained istoo highAseptic and sterility testing areas in operation set by–Annex 1and USP <1116>
24© Silliker Australia 2010
Trending Microbiological Data
The objective of a microbial monitoring program is to obtainrepresentative estimates of environmental bioburden
When data are compiled and analysed, any trends should beevaluated by trained personnel
While it is important to review environmental results on thebasis of recommended and specified frequency, it is alsocritical to review results over extended periods to determinewhether trends are present
The microbial control of controlled environments can beassessed, in part, on the basis of these trend dataR. Tirumalai USP, 2009 www.usp.org
25© Silliker Australia 2010
Trending Microbiological Data
Bar graphsLine graphsScatter chartsControl charts e.g.individuals chart•Pharmaceutical Microbiology
Forum Newsletter –Vol. 15(2),www.microbiologyforum.org
0
0.2
0.4
0.6
0.8
0 100 200 300 400 500 600 700 800
Observations
Mean UCL
I Chart
CF
U
26© Silliker Australia 2010
Trending Microbiological Data
CuSum analysis :•Is sensitive to small shifts in the
performance indicator•Is more sensitive to small changes
than a moving average chart•Not useful for cleanroom data that
are very low with many zero results•Computer assisted evaluation of
microbiological environmental controldata, Russell et al, J Pharma SciTechnol, Vol. 38, No. 3, 1984
-1.5-1
-0.50
0.51
1.52
CuS
UM
0 100 200 300 400 500 600 700Observations
CuSUM Graph
27© Silliker Australia 2010
For aseptic areas statistical analysis is often difficultbecause the results are too low –mostly zero
Mostly such facilities only yield 1 or 2 CFU fromhundreds of determinations
Use frequency between non-zero results as an event
Frequency of non-zero results is monitored
Environmental monitoring: data trending using afrequency model, Caputo and Huffman, J Pharm SciTechnol, Vol. 58, No. 5, 2004
Analysis of environmental microbiology data fromcleanroom samples, Hussong & Madson, PharmaTechnol January 1, 2004
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
0 1 2 3
CFU per Plate
Location A Location B
~1,200 Results fromSterility Testing Facility
Trending Microbiological Data
% Standard Deviation
+ 100/√Count
SD of 1 CFU is + 1 CFU
28© Silliker Australia 2010
Other References
Environmental monitoring: Myths and misapplications, Akers &Agallaco, J. Pharm. Sci Technol, Vol. 55, No. 3, 2001Environmental monitoring: Misconceptions and misapplications,Wilson, J. Pharm. Sci Technol, Vol. 55, No. 3, 2001Pharmaceutical Microbiology Forum (PMF)www.microbiologyforum.orgThe Microbiology Network - www.microbiol.orgControlled Environments Magazine–www.cemag.usMedical Device and Diagnostic Industry - www.mddionline.comPharmaceutical Technology - pharmtech.findpharma.comGlobal Society for Contamination Control - www.gsfcc.orgEvaluation of the Biovigilant IMD-A™, A novel optical spectroscopy technology for the continuous and real-time environmental monitoringof viable and nonviable particles, Parts 1 and 2, Miller et al, J PharmSci Technol, Vol. 63, No. 3, 2009